A clinician has called for more research and clinical guidance on menopause-related rage, arguing that the symptom remains underrecognized despite increased attention to menopause health. The discussion follows recent workplace policy initiatives and ongoing research into emotional symptoms during perimenopause.
Key Takeaways
- A clinician says menopause-related rage lacks dedicated clinical guidance.
- Existing menopause guidelines primarily address depression and anxiety symptoms.
- Researchers are studying irritability during perimenopause in an ongoing clinical trial.
- Recent workplace menopause policies have largely focused on physical symptoms.
- Experts say more research is needed to better understand severe emotional symptoms.
Menopause rage has become the focus of discussion after clinician Dr. Sarah Berg called for more research and clearer clinical guidance on severe emotional symptoms experienced during perimenopause. Berg argues that while public awareness and workplace policies addressing menopause have expanded, intense emotional reactions described by some women remain insufficiently studied and are not addressed through dedicated clinical recommendations.
The discussion follows several recent developments related to menopause health. Philanthropist Melinda French Gates announced a $215 million commitment to women’s health research and advocacy in June. During the same month, Washington Governor Bob Ferguson signed an executive order directing state agencies to incorporate menopause accommodations into workplace policies, while Illinois lawmakers advanced legislation that would require employers to provide reasonable accommodations for menopause-related conditions.
Although these initiatives address menopause more broadly, Berg said severe emotional symptoms require additional attention from researchers and healthcare professionals.
What Prompted the Discussion About Menopause Rage?
The current discussion began after Berg published an opinion piece urging the medical community to recognize what she described as an overlooked aspect of perimenopause. She stated that many women report experiencing episodes of intense emotional distress that they identify as rage rather than ordinary irritability.
According to Berg, many patients describe sudden emotional reactions that appear disproportionate to the situation and differ from mood changes they experienced earlier in life. She argues that existing discussions about menopause tend to emphasize physical symptoms such as hot flashes, sleep disruption, and cognitive difficulties. Separate reporting has also examined how menopause symptoms can affect employment and productivity, including recent findings on menopause workplace research and work ability.
Her comments also point to workplace implications. Berg stated that some women report modifying career plans, reducing travel responsibilities, or avoiding leadership opportunities because they are concerned about managing severe emotional symptoms during perimenopause.
The discussion has also included concerns about how workplace expectations may affect women differently depending on their personal and professional circumstances.
What Does Current Research Say About Emotional Symptoms During Perimenopause?
Researchers have long studied mood changes associated with menopause, although the evidence specifically examining severe anger or rage remains limited.
Hormonal changes during perimenopause, particularly fluctuations in estrogen levels, are known to influence neurotransmitter systems involved in mood regulation and stress responses. Healthcare professionals recognize that these hormonal changes can contribute to emotional symptoms alongside physical changes experienced during the menopause transition.
Findings From the SWAN Study
One of the largest sources of evidence is the Study of Women’s Health Across the Nation (SWAN), a long-running research project examining the menopause transition among women in the United States.
SWAN has reported that depressive symptoms become more common during perimenopause than during earlier reproductive years. Separate analyses have also examined symptoms including irritability, nervousness, fearfulness, and episodes of a racing heart.
Researchers found that women without a previous history of anxiety were more likely to report elevated levels of these symptoms during and after the menopause transition, even after accounting for factors such as hot flashes, stress, and general health.
Although irritability has been included in these analyses, researchers have generally evaluated it alongside other anxiety-related symptoms rather than treating severe emotional outbursts as a distinct clinical condition.
Ongoing Clinical Research
Research into emotional symptoms during perimenopause continues.
An ongoing federally funded clinical trial at the University of North Carolina is examining the neurophysiology of irritability during perimenopause. The study is supported by the National Institute of Mental Health and seeks to improve understanding of emotional symptoms that many women identify as particularly disruptive.
Investigators involved in the study have stated that many participants experiencing affective symptoms report irritability as one of their primary concerns. The research is intended to improve understanding of how hormonal changes affect emotional regulation during the menopause transition.
While this work addresses irritability, Berg argues that additional research specifically examining severe episodes commonly described by patients as rage remains limited. The discussion also comes as access to menopause care remains an issue for some patients, including those affected by the estrogen patch shortage that has limited availability of hormone therapy in some areas.
Why Do Experts Say Clinical Guidance Is Limited?
Current menopause clinical guidance includes recommendations for identifying and treating depression and other mood-related conditions, but experts note that specific guidance addressing menopause rage has not been established.
The Menopause Society released consensus guidance in 2018 focused on perimenopausal depression. Those recommendations advise clinicians to screen for depressive symptoms using validated assessment tools and to consider treatments such as psychotherapy or antidepressant medication when appropriate.
The guidance does not establish menopause-related rage as a separate diagnostic category.
Researchers have also noted that many published studies evaluate emotional symptoms using broader measures of anxiety or depression instead of examining severe anger independently. As a result, evidence specifically addressing diagnosis, treatment approaches, and long-term outcomes for menopause rage remains comparatively limited.
Berg argues that this gap makes it more difficult for healthcare providers and patients to identify the symptom consistently or determine the most appropriate clinical response.
Experts generally agree that additional research is necessary before new diagnostic criteria or treatment recommendations can be developed.
How Could Menopause Rage Affect Women in the Workplace?
Emotional symptoms associated with perimenopause can influence workplace experiences in several ways, according to clinicians and researchers.
Berg argues that some women may reduce professional responsibilities because they are uncertain about managing unpredictable emotional responses. She stated that some patients have reported stepping away from leadership positions or limiting work travel due to concerns about experiencing severe emotional reactions in professional settings.
Workplace Accommodation Policies
Recent workplace initiatives addressing menopause have largely concentrated on physical symptoms.
Washington state’s executive order directs agencies to incorporate menopause accommodations into workplace policy. Illinois lawmakers have also advanced legislation that would require employers to provide reasonable accommodations for menopause-related conditions if enacted.
Examples of workplace accommodations discussed in policy initiatives include access to temperature control, scheduling flexibility, and occupational health resources.
These measures primarily address physical aspects of menopause rather than emotional symptoms.
Concerns About Career Impact
Berg also argues that workplace consequences may differ among employees because expectations surrounding emotional expression are not experienced equally by everyone.
She cited concerns raised by women of color who reported feeling additional pressure to avoid displaying anger in professional settings. Berg referenced research examining workplace expectations surrounding emotional expression, particularly studies exploring how race and gender can influence perceptions of professional behavior.
Although evidence examining menopause rage and career outcomes remains limited, Berg said additional occupational health research could improve understanding of how emotional symptoms affect employment decisions during midlife.
Researchers have acknowledged that workplace effects related specifically to severe emotional symptoms remain an area requiring further investigation.
Frequently Asked Questions
What is menopause rage?
Menopause rage is an informal term used to describe episodes of intense anger or emotional distress that some women report experiencing during perimenopause. It is not currently recognized as a separate medical diagnosis.
How is menopause rage different from irritability?
Some clinicians distinguish menopause rage from irritability by describing it as a more intense emotional response. However, most clinical research currently measures irritability rather than treating menopause rage as its own research category.
What research exists on menopause rage?
Research has examined mood changes, depression, anxiety, and irritability during perimenopause through studies such as the Study of Women’s Health Across the Nation. An ongoing clinical trial is also investigating irritability during perimenopause, but research specifically focused on menopause rage remains limited.
Are there clinical guidelines for menopause rage?
No dedicated clinical guidelines currently address menopause rage as a separate condition. Existing menopause guidance primarily focuses on screening and treating depression and related mood disorders.
